Showing results (201-210 of 361) with videos related to
Sort By:
Pageof 37
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentGuilherme Povala, Guilherme Bauer-Negrini, Bruna Bellaver, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 25, 2024
Down Syndrome Biobank Consortium: A perspectiveIban Aldecoa, Isabel Barroeta, Steven L Carroll, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 5, 2015
Cerebral amyloid angiopathy-related atraumatic convexal subarachnoid hemorrhage: an ARIA before the tsunamiEva Martínez-Lizana, María Carmona-Iragui, Daniel Alcolea, et al.Brain : a Journal of Neurology|March 26, 2019
Cortical microstructure in the behavioural variant of frontotemporal dementia: looking beyond atrophyIgnacio Illán-Gala, Victor Montal, Sergi Borrego-Écija, et al.JAMA Network Open|May 23, 2022
Association of Alzheimer Disease With Life Expectancy in People With Down SyndromeMaria Florencia Iulita, Diana Garzón Chavez, Maria Klitgaard Christensen, et al.Alzheimer'S Research & Therapy|February 2, 2022
The Aβ1-42/Aβ1-40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1-42 aloneConstance Delaby, Teresa Estellés, Nuole Zhu, et al.Neurology|September 11, 2020
Cortical microstructure in the amyotrophic lateral sclerosis-frontotemporal dementia continuumIgnacio Illán-Gala, Victor Montal, Jordi Pegueroles, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Clinical ManifestationsLaura Del Hoyo, Katja Sandkühler, Laura Videla, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 14, 2024
Adapting prescribing criteria for amyloid-targeted antibodies for adults with Down syndromeHampus Hillerstrom, Richard Fisher, Matthew P Janicki, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 3, 2025
Generational effects in Down syndrome: Enriched environment enhances functionality without reducing Alzheimer's disease riskLídia Vaqué-Alcázar, Laura Videla, Bessy Benejam, et al.Pageof 37